Multi Medika Internasional Stock Current Valuation
| MMIX Stock | 153.00 5.00 3.38% |
Valuation analysis of Multi Medika Interna helps investors to measure Multi Medika's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Multi Medika's price fluctuation is very steady at this time. Calculation of the real value of Multi Medika Interna is based on 3 months time horizon. Increasing Multi Medika's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Multi Medika's intrinsic value may or may not be the same as its current market price of 153.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 153.0 | Real 153.25 | Hype 153.0 | Naive 208.78 |
The intrinsic value of Multi Medika's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Multi Medika's stock price.
Estimating the potential upside or downside of Multi Medika Internasional helps investors to forecast how Multi stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Multi Medika more accurately as focusing exclusively on Multi Medika's fundamentals will not take into account other important factors: Multi Medika Internasional Company Current Valuation Analysis
Multi Medika's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Multi Medika Internasional has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The current valuation for all Indonesia stocks is 100.0% higher than that of the company.
Multi Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Multi Medika's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Multi Medika could also be used in its relative valuation, which is a method of valuing Multi Medika by comparing valuation metrics of similar companies.Multi Medika is currently under evaluation in current valuation category among its peers.
Multi Fundamentals
| Return On Equity | 1.81 | |||
| Return On Asset | 0.37 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.18 % | |||
| Shares Owned By Insiders | 7.00 % | |||
| Price To Sales | 3.41 X | |||
| Revenue | 181.84 B | |||
| Gross Profit | 67.57 B | |||
| EBITDA | 33.57 B | |||
| Book Value Per Share | 27.86 X | |||
| Number Of Employees | 63 | |||
| Market Capitalization | 1.27 T |
About Multi Medika Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Multi Medika Internasional's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multi Medika using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multi Medika Internasional based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.